Cell & Gene Therapy on the platform
Computational tools for CAR-T design, construct assembly, NK-CAR design, KIR matching, and related scoring workflows.
Some tools on this page are retired
This page documents working tools alongside tools that have been retired. The retired ones can no longer be run:
cart_manufacturing_score— use cart_construct_build for the construct composition; the manufacturing score was withdrawn 2026-10-04 and nothing replaces itcart_safety_predict— use cart_construct_build / cart_scfv_design for construct composition; the CRS and neurotoxicity predictions were withdrawn 2026-10-04 and nothing replaces themnk_cytotoxicity_predict— use nk_car_design / nk_kir_match; the NK cytotoxicity prediction was withdrawn 2026-10-04 and nothing replaces it
Everything else on this page still works.
Design and evaluate CAR-T and NK cell therapies end to end — from antigen binder design through construct assembly, safety and manufacturing assessment, and NK-specific receptor and donor-matching analysis. Reach for these tools when your program is a cell therapy rather than a small molecule, and you need computational feasibility scores before committing to wet-lab work. They sit in the translational, experimental-biology arc of discovery, feeding downstream into safety and clinical-trial matching. See the Cell & Tissue overview for where this fits.
Cell & Gene Therapy overview
The Cell & Gene Therapy toolkit provides seven complementary tools spanning the CAR-T and NK cell therapy design pipeline. Tools cover antigen binder design, construct engineering, safety assessment, manufacturing evaluation, and NK cell biology. All tools run on hosted GPU compute and return results in 30-180 seconds.
Three tools currently always fail
cart_safety_predict, cart_manufacturing_score, and nk_cytotoxicity_predict return an error on every call. Each previously scored its output from a hand-tuned sequence-descriptor heuristic with no trained model or clinical/manufacturing/cytotoxicity dataset behind it, and the backend now refuses to return that as a real prediction rather than ship a fabricated number. Use them only to see the refusal message; the four other tools (cart_scfv_design, cart_construct_build, nk_car_design, nk_kir_match) run and return real results.
Architecture
Tool inventory
CAR-T design tools
| Tool | Name | Description | Key Output |
|---|---|---|---|
| CAR-T ScFv Design | cart_scfv_design | Generates ScFv candidates with optimized CDR regions for target binding | Ranked ScFv sequences, binding affinity predictions, humanization scores |
| CAR Construct Build | cart_construct_build | Assembles full CAR constructs from ScFv, hinge, transmembrane, and signaling domains | Complete CAR sequence, domain annotations, codon-optimized DNA |
CAR-T evaluation tools
| Tool | Name | Description | Key Output |
|---|---|---|---|
| CAR-T Safety Predict ⚠︎ always fails | cart_safety_predict | Refuses to run — no trained model backs a CRS/ICANS prediction | Error only |
| CAR-T Manufacturing Score ⚠︎ always fails | cart_manufacturing_score | Refuses to run — no trained model backs a manufacturing-feasibility prediction | Error only |
NK cell therapy tools
| Tool | Name | Description | Key Output |
|---|---|---|---|
| NK-CAR Design | nk_car_design | Designs NK-optimized CAR receptors with NK-specific signaling | NK-CAR sequences, signaling configurations, activation predictions |
| NK KIR Match | nk_kir_match | Scores one HLA allele set against a curated KIR-HLA reference table | Per-KIR-gene match type and alloreactivity, overall score |
| NK Cytotoxicity Predict ⚠︎ always fails | nk_cytotoxicity_predict | Refuses to run — no trained model or assay backs a lysis/EC50 prediction | Error only |
Capabilities
ScFv candidate design
The ScFv design tool generates single-chain variable fragment candidates for a target antigen (sequence or UniProt ID) using deep learning. Optionally seed it with a starting vh_sequence/vl_sequence to optimize an existing lead instead of designing de novo. Choose the linker with linker_type (G4S, flexible, or rigid) and how many candidates to generate with num_designs (default 10).
CAR construct assembly
The construct builder assembles a complete chimeric antigen receptor sequence from an scFv plus modular components: hinge (CD8, IgG4, or CD28), transmembrane domain (CD28 or CD8), a costimulatory domain (41BB, CD28, OX40, or ICOS), and the CD3-zeta signaling domain. generation selects 2, 3, or 4 — there's no first-generation (CD3-zeta-only) option.
Safety and toxicity prediction — always fails
cart_safety_predict takes a full CAR construct_sequence and target_antigen, but every call returns an error rather than a CRS/neurotoxicity risk level: the previous scores came from an instability-index/GRAVY heuristic with no clinical dataset behind them, and the backend now refuses to ship that as a prediction.
Manufacturing feasibility scoring — always fails
cart_manufacturing_score takes a CAR construct_sequence and a delivery vector_type (lentiviral, retroviral, or transposon; default lentiviral), but every call returns an error rather than a feasibility score: the previous scores came from sequence-length/instability formulas with no manufacturing dataset behind them.
NK-CAR receptor design
NK-CAR design creates a CAR receptor for a target_antigen using NK-specific components: an activating_receptor (NKG2D, DNAM1, NKp30, or NKp44; default NKG2D), a transmembrane domain (NKG2D, DAP10, or CD28), and an intracellular signaling_domain (DAP10, DAP12, or CD3z_2B4; default DAP10).
KIR-HLA scoring
nk_kir_match scores a single set of HLA alleles (hla_alleles) against a curated KIR-HLA reference table, returning per-KIR-gene match type and predicted alloreactivity plus an overall alloreactivity_score. It does not compare a donor genotype against a recipient genotype — the tool interface also accepts donor_kir_genotype, recipient_hla (as gene/allele flag objects), and analysis_type, but the executing backend reads none of them; only hla_alleles affects the result.
NK cytotoxicity prediction — always fails
nk_cytotoxicity_predict takes the target cell's HLA expression (target_cell_hla) and optional stress ligands (target_ligands) and NK receptor profile (nk_receptors), but every call returns an error rather than a lysis prediction: the previous numbers came from a Hill-equation-shaped heuristic with no cytotoxicity assay behind them.
When to use each tool
| I want to... | Use this tool |
|---|---|
| Design a new CAR-T targeting a specific antigen | cart_scfv_design |
| Assemble a complete CAR construct | cart_construct_build |
| Assess CRS and neurotoxicity risk | cart_safety_predict — currently always returns an error |
| Evaluate if a construct can be manufactured | cart_manufacturing_score — currently always returns an error |
| Design a CAR for NK cells | nk_car_design |
| Score KIR-HLA alloreactivity for one allele set | nk_kir_match |
| Predict how well NK cells will kill a tumor | nk_cytotoxicity_predict — currently always returns an error |
| Run the working part of the CAR-T design pipeline | cart_scfv_design + cart_construct_build |
When to use other tools instead
| I want to... | Use this instead |
|---|---|
| Validate target antigen expression | OpenTargets associations or other Genomics lookups |
| Predict 3D structure of ScFv | ESMFold, or AlphaFold DB for a known protein |
| Dock ScFv to target antigen | DiffDock |
| Search for antibody sequences | UniProt or the antibody databases |
| Assess small molecule drug safety | ADMETlab 3 or a Safety Passport |
| Search for cell therapy clinical trials | ClinicalTrials.gov |
| Analyze protein-protein interactions | A STRING interaction lookup |
CAR architecture reference
cart_construct_build's generation parameter accepts 2, 3, or 4 (default 2) and pairs with a single costimulatory domain choice (41BB, CD28, OX40, or ICOS) plus the fixed CD3-zeta signaling domain. There's no first-generation (CD3-zeta-only, no costimulatory domain) option in this tool.
Citations
June CH, et al. CAR T cell immunotherapy for human cancer. Science. 2018;359(6382):1361-1365. doi: 10.1126/science.aar6711
Liu E, et al. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. N Engl J Med. 2020;382(6):545-553. doi: 10.1056/NEJMoa1910607
Ruggeri L, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. doi: 10.1126/science.1068440
Chat Usage
Example Prompts
- "Design ScFv candidates for targeting BCMA on multiple myeloma cells"
- "Build a generation-2 4-1BB/CD3-zeta CAR construct using this ScFv sequence"
- "Design an NK-CAR with DAP12 signaling for targeting GPC3"
- "Find the best NK cell donor match for this patient's HLA type"
Workflow Chaining
- Feeds into: Safety Passport (toxicity assessment), Compound Passport (combination therapy), Clinical Trial matching, ESMFold/AlphaFold (ScFv structure prediction)
- Accepts from: Genomics tools (target gene data), UniProt (protein sequences), OpenTargets (target validation), Literature search (clinical evidence), Antibody database tools (existing binder sequences)
FAQ
Read next
Cytometry on the platform
FlowSOM clustering and imaging mass cytometry segmentation and spatial analysis for flow, mass, and imaging cytometry data.
Pathology on the platform
Digital pathology analysis for whole slide images.
Which tool?
Match a scientific goal to the tool that answers it.
Workflows
Guided pipelines and copy-and-adapt prompt recipes for common goals.
Was this page helpful?